Can lymphatic vascular density be used in determining metastatic spreading potential of tumor in invasive ductal carcinomas?

Pathology and Oncology Research

Volumn 18, Issue 2, 2012, Pages 253-262

  Kandemir, Nilufer Onak ^a   Barut, Figen ^a   Bektas, Sibel ^a   Ozdamar, Sukru Oguz ^a  

^a ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

Author keywords

Breast carcinoma; D2 40; Lymhangiogenesis; Lymphatic vessel invasion

Indexed keywords

MONOCLONAL ANTIBODY D2-40;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BLOOD VESSEL PARAMETERS; BREAST CARCINOMA; CANCER CELL; CANCER INVASION; CANCER PROGNOSIS; CANCER SIZE; CANCER STAGING; CANCER TISSUE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHANGIOGENESIS; LYMPHATIC VASCULAR DENSITY; MAJOR CLINICAL STUDY; MASTECTOMY; METASTASIS POTENTIAL; MICROVASCULATURE; TUMOR VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIGENS, CD31; AXILLA; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL PROLIFERATION; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPH NODE EXCISION; LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; MASTECTOMY; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 84863475193     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-011-9436-1     Document Type: Article

References (45)

1. Ellis LM, Fidler IJ (1995) Angiogenesis and breast cancer metastasis. Lancet 12:388-390
2. Kato T, Kameoka S, Kimura T et al (2003) The combination of angiogenesis and blood vessel invasion as a prognostic indicator in primary breast cancer. Br J Cancer 88:1900-1908
3. Casadio C, Luini A, Veronesi P et al (2007) Prognostic role of the extent of peritumoral vascular invasion in operable breast cancer. Ann Oncol 18:1632-1640
4. Ogiya A, Kahn HJ, Marks A (2002) A new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors. Lab Invest 82:1255-1257
5. Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19:403-410
6. Greene FL, Page DL, Fleming ID et al (2002) Breast. In: Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M (eds) AJCC cancer staging manual, 6th edn. Springer, New York, pp 223-240
7. Harvey JM, Clark GM, Osborne K et al (1999) Estrogen receptor status by immunohistochemistry is superior to the ligandbinding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 17:1474-1481
8. Yaziji H, Taylor CR (2007) Begin at the beginning, with the tissue! The key message underlying the ASCO/CAP Task-force Guideline Recommendations for HER2 testing. Appl Immunohistochem Mol Morphol 15:239-241
9. Weidner N (1995) Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res Treat 36:169-180
10. Saad RS, Lindner JL, Liu Y et al (2009) Lymphatic vessel density as prognostic marker in esophageal adenocarcinoma. Am J Clin Pathol 131:92-98
11. Vermeulen PB, Gasparini G, Fox SB et al (1996) Quantification of angiogenesis in solid human tumors: an international consensus on the morphology and criteria of evaluation. Eur J Cancer 32:2474-2484
12. Saad RS, Kordunsky L, Denning KL et al (2006) Lymphatic microvessel density as prognostic marker in colorectal carcinoma. Mod Pathol 19:1317-1323
13. Kawamura L, Carvalho FM, Alves BG et al (2010) Association between intratumoral lymphatic microvessel density (LMVD) and clinicopathologic features in endometrial cancer: a retrospective cohort study. World J Surg Oncol 14(8):89
14. De Mascarel I, MacGrogan G, Debled M et al (2009) D2-40 in breast cancer: should we detect more vascular emboli? Mod Pathol 22:216-222
15. Agarwal B, Saxena R, Moriyama A et al (2005) Lymphangiogenesis does not occur in breast cancer. Am J Surg Pathol 29:1449-1455
16. Colleoni M, Rotmensz N, Maisonneuve P et al (2007) Prognostic role of the extent of peritumoral vascular invasion in operable breast cancer. Ann Oncol 18(10):1632-1640
17. Beasley NJ, Prevo R, Banerji S et al (2002) Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res 62:1315-1320
18. Yamauchi C, Hasebe T, Iwasaki M et al (2007) Accurate assessment of lymph vessel tumor emboli in invasive ductal carcinoma of the breast according to tumor areas, and their prognostic significance. Hum Pathol 38:247-259
19. Nathanson SD (2003) Insights into the mechanisms of lymph node metastasis. Cancer 98:413-423
20. Achen MG, Stacker SA (2008) Molecular control of lymphatic metastasis. Ann N Y Acad Sci 1131:225-234
21. Shayan R, Achen MG, Stacker SA (2006) Lymphatic vessels in cancer metastasis: bridging the gaps. Carcinogenesis 27:1729-1738
22. Van der Auwera I, Van den Eynden GG, Colpaert CG et al (2005) Tumor lymphangiogenesis in inflammatory breast carcinoma: a histomorphometric study. Clin Cancer Res 11:7637-7642
23. Donoghue JF, Lederman FL, Susil BJ et al (2007) Lymphangiogenesis of normal endometrium and endometrial adenocarcinoma. Hum Reprod 22:1705-1713
24. Grossklaus DJ, Coffey CS, Shappell SB et al (2002) Percent of cancer in the biopsy set predicts pathological findings after prostatectomy. J Urol 167:2032-2035
25. Franchi A, Gallo O, Massi D et al (2004) Tumor lymphangiogenesis in head and neck squamous cell carcinoma: a morphometric study with clinical correlations. Cancer 101:973-978
26. Massi D, Puig S, Franchi A et al (2006) Tumour lymphangiogenesis is a possible predictor of sentinel lymph node status in cutaneous melanoma: a case-control study. J Clin Pathol 59:166-173
27. Van der Schaft DW, Pauwels P, Hulsmans S et al (2007) Absence of lymphangiogenesis in ductal breast cancer at the primary tumor site. Cancer Lett 28:128-136
28. Schloppmann SF, Birner P, Studer P et al (2001) Lymphatic microvessel densitiy and lymphovascular invasion assessed by anti-podoplanin immunostaining in human breast cancer. Anticancer Res 21:2351-2355
29. Van der Auwera I, Cao Y, Tille JC et al (2006) First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours. Br J Cancer 18:1611-1625
30. Britto AV, Schenka AA, Moraes-Schenka NG et al (2009) Immunostaining with D2-40 improves evaluation of lymphovascular invasion, but may not predict sentinel lymph node status in early breast cancer. BMC Cancer 8(9):109
31. Marinho VF, Metze K, Sanches FS et al (2008) Lymph vascular invasion in invasive mammary carcinomas identified by the endothelial lymphatic marker D2-40 is associated with other indicators of poor prognosis. BMC Cancer 29(8):64
32. Ito M, Moriya T, Ishida T et al (2007) Significance of pathological evaluation for lymphatic vessel invasion in invasive breast cancer. Breast Cancer 14:381-387
33. El-Gohary YM, Metwally G, Saad RS et al (2008) Prognostic significance of intratumoral and peritumoral lymphatic density and blood vessel density in invasive breast carcinomas. Am J Clin Pathol 129:578-586
34. Ejlertsen B, Jensen MB, Rank F et al (2009) Population-based study of peritumoral lymphovascular invasion and outcome among patients with operable breast cancer. J Natl Cancer Inst 101:729-735
35. Arnaout-Alkarain A, Kahn HJ, Narod SA et al (2007) Significance of lymph vessel invasion identified by the endothelial lymphatic marker D2-40 in node negative breast cancer. Mod Pathol 20:183-191
36. Beasley N, Prevo R, Banerji S et al (2002) Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res 62:1315-1320
37. Dadras SS, Bertoncini J, Brown L et al (2003) Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival. Am J Pathol 162:1951-1960
38. Van den Eynden GG, Van der Auwera I, Van Laere SJ et al (2006) Induction of lymphangiogenesis in and around axillary lymph node metastases of patients with breast cancer. Br J Cancer 20:1362-1366
39. Van den Eynden GG, Van der Auwera I, Van Laere SJ et al (2007) Comparison of molecular determinants of angiogenesis and lymphangiogenesis in lymph node metastases and in primary tumours of patients with breast cancer. J Pathol 213:56-64
40. Mylona E, Nomikos A, Alexandrou P et al (2007) Lymphatic and blood vessel morphometry in invasive breast carcinomas: relation with proliferation and VEGF-C and -D proteins expression. Histol Histopathol 22:825-835
41. Mohammed RA, Ellis IO, Elsheikh S et al (2009) Lymphatic and angiogenic characteristics in breast cancer: morphometric analysis and prognostic implications. Breast Cancer Res Treat 113:261-273
42. Witte MH, Jones K, Wilting J et al (2006) Structure function relationships in the lymphatic system and implications for cancer biology. Cancer Metastasis Rev 6:159-184
43. Williams CS, Leek RD, Robson AM et al (2003) Absence of lymphangiogenesis and intratumoural lymph vessels in human metastatic breast cancer. J Pathol 200:195-206
44. Colleoni M, Rotmensz N, Maisonneuve P et al (2007) Prognostic role of the extent of peritumoral vascular invasion in operable breast cancer. Ann Oncol 18:1632-1640
45. Choi WW, Lewis MM, Lawson D et al (2005) Angiogenic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopathologic parameters and VEGF-family gene expression. Mod Pathol 18:143-152